This makes Cyprio the holder of a unique technology (BioPearl) for fabrication of spheroids that are physiologically more relevant than traditional monolayer models and are compatible with high throughput screening applications. Our first product, HepatoPearl, has been validated as a beneficial in vitro hepatic model for various applications, such as screening
of drug-drug interactions, in vitro toxicology and metabolism of low clearance compounds. Currently, Cyprio is expanding its product range by using its breakthrough technology to definitively change liver cell-culture biology approaches towards more complex and more relevant, yet more robust, easier to handle and HTS compatible 3D cellular models.